Website intended for a NZ health professional readership
How safe and effective is hormone replacement therapy for menopausal symptoms in women surgically treated for epithelial ovarian cancer?
HRT may improve overall survival in wom- en who have undergone surgery for EOC. However, this is based on low‐certainty evidence and, therefore, should be interpreted with caution. We are very uncertain about the impact of HRT on progression‐free survival and incidence of adverse events, such as breast cancer, transient ischaemic accident, cerebrovascular accident and myocardial infarction. Therefore, women and their doctors should make decisions based on individual priorities and symptoms.
None of the studies were blinded and 2 studies had high rates of discontinuation of therapy or loss to follow-up. One study was based in Europe and was multicentred, with the remaining 2 from China and South Africa.
Women who have undergone surgical treatment for EOC may develop menopausal symptoms due to immediate loss of ovarian function following surgery and chemotherapy. Women may experience vasomotor symptoms, sleep disturbance, difficulty concentrating, sexual dysfunction, vaginal symptoms and accelerated osteoporosis. Although HRT is the most effective treatment to relieve these symptoms, its safety has been questioned for women with EOC.
Saeaib N et al. Hormone replacement therapy after surgery for epithelial ovarian cancer. Cochrane Database Syst Rev 2020, Issue 1. Art. No.: CD012559. DOI: 10.1002/14651858.CD012559.pub2. This review contains 3 studies involving 370 participants.
Prostate cancer consultations are common in primary care and there is no one approach to testing and treatment that fits all patients. Urologist Simon van Rij discusses the key considerations and options for personalised care, appropriate investigation and treatment
![Amtech Medical marketing manager Jasmine Anderson and Ebos Health senior account manager Sageran Naidoo [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2024-09/2%28a%29.JPG?itok=Jdm5dZdg)
![Medtech CEO Geoffrey Sayer and MyPractice founder and Auckland-based specialist GP Ashwin Patel [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2024-09/3%28a%29.JPG?itok=LdPwyQwJ)
![Mahoe Medical Centre administration managers Ashlee Herbert and Julie-Ann Foreman [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2024-09/4%28b%29.JPG?itok=_NUoSaY2)
![Broadway Health Management Centre administrators Stef LeGros and Julie Johnson [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2024-09/5%28b%29.JPG?itok=Q5P9RMB1)
![Newtown Union Health Service administrators Tunisia Pohatu and Waty Arief-Macher [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2024-09/6%28a%29.JPG?itok=ttzKlXLf)
![SR Referrals client support staff Athulya Mohandas and Shona Cribb and support manager Amy Moyle [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2024-09/7%28a%29.JPG?itok=11zaUO5S)
![Webtools implementation specialist Hannah Laurie and head of marketing Bridget Holland [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2024-09/11%28b%29.JPG?itok=4Q_1zwTg)
![DataCraft Analytics operations manager Rachel Blanch and managing director Jayden Macrae [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2024-09/1%28c%29.JPG?itok=ipS4z2aa)
![Collaborative Aotearoa CEO Jess Morgan-French, Three Rivers Medical general manager Michelle Te Kira and Third Age Health chief executive Tony Wai [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2024-09/10%28a%29.JPG?itok=t2X4h7nC)
